Brain Metastatic Lung Cancer Patients: A Multitarget Therapeutic-Supportive Strategy with Anti-STAT3 Silibinin.

NeuroSci · 2025 · PMC12736038 · PMID 41441207

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

nearly significantp = 0.07so close (0.05 < p ≤ 0.1)

Interestingly, in the subgroup of ADK patients, QoL scores tended to improve (from 58.3 to 66.7), with a nearly significant trend ( p = 0.07, Figure 3 ).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.